A central role for monocytes in Toll-like receptor-mediated activation of the vasculature.
There is increasing evidence that activation of inflammatory responses in a variety of tissues is mediated co-operatively by the actions of more than one cell type. In particular, the monocyte has been implicated as a potentially important cell in the initiation of inflammatory responses to Toll-like receptor (TLR)-activating signals. To determine the potential for monocyte-regulated activation of tissue cells to underpin inflammatory responses in the vasculature, we established cocultures of primary human endothelial cells and monocytes and dissected the inflammatory responses of these systems following activation with TLR agonists. We observed that effective activation of inflammatory responses required bidirectional signalling between the monocyte and the tissue cell. Activation of cocultures was dependent on interleukin-1 (IL-1). Although monocyte-mediated IL-1beta production was crucial to the activation of cocultures, TLR specificity to these responses was also provided by the endothelial cells, which served to regulate the signalling of the monocytes. TLR4-induced IL-1beta production by monocytes was increased by TLR4-dependent endothelial activation in coculture, and was associated with increased monocyte CD14 expression. Activation of this inflammatory network also supported the potential for downstream monocyte-dependent T helper type 17 activation. These data define co-operative networks regulating inflammatory responses to TLR agonists, identify points amenable to targeting for the amelioration of vascular inflammation, and offer the potential to modify atherosclerotic plaque instability after a severe infection.
Ward
Jon R
JR
Cardiovascular Research Unit, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, UK.
Francis
Sheila E
SE
Marsden
Luke
L
Suddason
Tesha
T
Lord
Graham M
GM
Dower
Steven K
SK
Crossman
David C
DC
Sabroe
Ian
I
D002450:Cell Communication / Q000276:immunology; D002470:Cell Survival / Q000276:immunology; D018920:Coculture Techniques; D016207:Cytokines / Q000096:biosynthesis; D004306:Dose-Response Relationship, Immunologic; D042783:Endothelial Cells / Q000276:immunology; D004730:Endothelium, Vascular / Q000166:cytology / Q000276:immunology*; D006801:Humans; D007249:Inflammation / Q000276:immunology; D007375:Interleukin-1 / Q000096:biosynthesis / Q000276:immunology; D018950:Lipopolysaccharide Receptors / Q000378:metabolism; D008070:Lipopolysaccharides / Q000276:immunology; D009000:Monocytes / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D051195:Toll-Like Receptor 2 / Q000819:agonists; D051193:Toll-Like Receptors / Q000276:immunology*
D016207:Cytokines; D007375:Interleukin-1; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; C495342:TLR2 protein, human; D051195:Toll-Like Receptor 2; D051193:Toll-Like Receptors
Blood. 2007 Feb 15;109(4):1574-83
17038528
Circulation. 2008 May 20;117(20):2670-83
18474815
Annu Rev Pathol. 2008;3:99-126
18039143
Thromb Haemost. 2005 Oct;94(4):831-8
16270639
J Allergy Clin Immunol. 2007 Aug;120(2):247-54
17666214
Circ Res. 2001 Aug 3;89(3):244-50
11485974
Clin Exp Immunol. 2007 Feb;147(2):199-207
17223959
Cardiovasc Res. 2005 Dec 1;68(3):493-501
16099441
J Endotoxin Res. 2006;12(3):133-50
16719986
N Engl J Med. 2002 Jul 18;347(3):185-92
12124407
Curr Opin Immunol. 2007 Jun;19(3):281-6
17433650
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1966-71
12569171
Circulation. 2002 Mar 12;105(10):1158-61
11889007
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17034-9
17942669
Curr Opin Investig Drugs. 2005 May;6(5):496-502
15912963
Clin Immunol. 2008 Apr;127(1):89-97
18294918
J Immunol. 2001 Jan 1;166(1):249-55
11123299
J Biol Chem. 2000 Apr 14;275(15):11058-63
10753909
J Immunol. 2002 May 1;168(9):4701-10
11971020
FASEB J. 2006 Oct;20(12):2153-5
16935934
J Exp Med. 1993 Dec 1;178(6):2193-200
7504060
J Biol Chem. 1997 May 2;272(18):11778-85
9115233
J Endotoxin Res. 2001;7(4):322-6
11717590
N Engl J Med. 2004 Dec 16;351(25):2611-8
15602021
J Immunol. 2008 Oct 15;181(8):5606-17
18832719
J Leukoc Biol. 2004 Sep;76(3):514-9
15178705
Br J Pharmacol. 2007 May;151(1):115-27
17351655
Am J Respir Crit Care Med. 2005 Apr 15;171(8):814-22
15657467
Annu Rev Immunol. 2007;25:821-52
17201677
J Am Coll Cardiol. 1999 Dec;34(7):1975-81
10588212
Atherosclerosis. 2007 Feb;190(2):443-51
16569408
Am Heart J. 2005 Sep;150(3):488-99
16169330
Nat Med. 2007 Jul;13(7):851-6
17572686
J Immunol. 1991 Mar 1;146(5):1437-45
1993838
J Immunol. 2003 Aug 15;171(4):1630-5
12902458
N Engl J Med. 2005 Apr 21;352(16):1685-95
15843671
J Clin Invest. 2003 Apr;111(7):1011-20
12671050
Am J Pathol. 2006 Apr;168(4):1396-403
16565512
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10679-84
15249654
Immunity. 2001 Nov;15(5):825-35
11728343